¼¼°èÀÇ ´Éµ¿ À̽ÄÇü ÀÇ·á±â±â(AIMD) ½ÃÀå ¿¹Ãø(2025-2030³â)
Active Implantable Medical Devices (AIMD) Market - Forecasts fom 2025 to 2030
»óǰÄÚµå : 1800209
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 146 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,547,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,390,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,760,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ´Éµ¿ À̽ÄÇü ÀÇ·á±â±â(AIMD) ½ÃÀåÀº CAGR 6.93%·Î È®´ëµÇ¾î 2025³â 351¾ï 9,500¸¸ ´Þ·¯¿¡¼­ 2030³â±îÁö 491¾ï 9,700¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ´Éµ¿ À̽ÄÇü ÀÇ·á±â±â(AIMD) ½ÃÀåÀº ±â¼úÀÇ Áøº¸, Àα¸ÀÇ °í·ÉÈ­, ¸¸¼º ÁúȯÀÇ À¯º´·üÀÇ »ó½Â¿¡ °ßÀεǾî Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ½É¹Ú Á¶À²±â ¹× ½Å°æ ÀÚ±Ø ÀåÄ¡¿Í °°Àº AIMD´Â ƯÈ÷ ³ëÀÎÀÇ »óŸ¦ ¸ð´ÏÅ͸µÇϰí Ä¡·áÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

1. °í·ÉÈ­ »çȸ¿¡¼­ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡ : °í·ÉÀÚÀÇ ½ÉÇ÷°ü Áúȯ, ´ç´¢º´, ½Å°æ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡´Â AIMD ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â º¹ÀâÇÑ °Ç°­ °ü¸®ÀÇ ¿ä±¸¸¦ °ü¸®Çϰí, ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí, »îÀÇ ÁúÀ» ³ôÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ³ëÀÎ Àα¸ÀÇ ¼¼°è Áõ°¡´Â °Ç°­ °ü¸® Á¦°ø¾÷ü°¡ ³ëÈ­¿Í °ü·ÃµÈ °Ç°­ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ °í±Þ ¼Ö·ç¼ÇÀ» ¿ä±¸Çϱ⠶§¹®¿¡ AIMD¿¡ ´ëÇѼö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

2. ±â¼ú Áøº¸¿Í AI ÅëÇÕ : ȯÀÚ¿¡ ƯȭµÈ Áø´ÜÀ» À§ÇÑ ÀΰøÁö´É(AI)ÀÇ ÅëÇÕ°ú °°Àº AIMD ±â¼úÀÇ Çõ½ÅÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. AI ´ëÀÀ ±â±â´Â ¸ð´ÏÅ͸µÀÇ Á¤¹Ðµµ¿Í Ä¡·á È¿°ú¸¦ ³ô¿© º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß°ú ±âÁ¸ AIMDÀÇ ÀûÀÀ È®´ë´Â ±â¼ú Çõ½ÅÀ» ´õ¿í ÃËÁøÇÏ°í ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÚ¸®Àâ°í ÀÖ½À´Ï´Ù.

3. Á¤ºÎ Áö¿ø Á¤Ã¥°ú ÀÚ±Ý Áö¿ø : Çѱ¹ÀÇ 'ÀÇ·á±â±â »ê¾÷ À°¼º°ú Çõ½ÅÀûÀÎ ÀÇ·á±â±â Áö¿ø¿¡ °üÇÑ ¹ý·ü' µîÀÇ ±ÔÁ¦Àû ƲÀÌ AIMD °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀÚ±Ý Áö¿ø°ú AIMDÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀÎÁöµµ Çâ»óÀº ¿¬±¸ ¹× Á¦Ç° Ãâ½Ã¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇÏ°í ½ÃÀå È®´ë¸¦ Áö¿øÇÕ´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

1. °íºñ¿ë°ú ±ÔÁ¦»óÀÇ °úÁ¦ : AIMDÀÇ °³¹ß ¹× Á¦Á¶ ºñ¿ëÀº ³ô°í, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Çµµ ÇÔ²² ½ÃÀå ¼ºÀåÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ¼¼°è Ç¥ÁØÀ» ÁؼöÇϸé Á¦Á¶ ºñ¿ë°ú ÀÏÁ¤À» ´Ã¸®°í ºñ¿ë¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼­ÀÇ »ç¿ëÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

2. ½ÅÈï ½ÃÀå¿¡¼­ ³·Àº ÀÎÁöµµ : ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½¿¡µµ ºÒ±¸Çϰí, ƯÁ¤ Áö¿ª, ƯÈ÷ ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­´Â AIMDÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎÁöµµ°¡ ³·¾Æ ½ÃÀå ħÅõ¸¦ ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. AIMDÀÇ ÀåÁ¡¿¡ ´ëÇØ ÀÇ·á Á¾»çÀÚ¿Í È¯ÀÚ¸¦ ±³À°ÇÏ´Â °ÍÀº ¿©ÀüÈ÷ Áß¿äÇÑ °úÁ¦ÀÔ´Ï´Ù.

Áö¿ªº° Àü¸Á

ÁÖ¿ä ¹ßÀü(2023-2025³â)

½ÃÀå Àü¸Á

AIMD ½ÃÀåÀº ¸¸¼ºÁúȯ ºÎ´ã Áõ°¡, ±â¼ú Áøº¸, Áö¿ø Á¤Ã¥¿¡ °ßÀεǾî 2025³â±îÁö °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¹Ì±¹Àº °í·ÉÈ­°¡ ÁøÇàµÇ°í Áúº´ÀÇ ÀÌȯÀ²ÀÌ ³ô±â ¶§¹®¿¡ ½ÃÀåÀ» ¼±µµÇϰí ÀÖÁö¸¸, ¾Æ½Ã¾ÆÅÂÆò¾çÀº Å« °¡´É¼ºÀ» Áö´Ï°í ÀÖ½À´Ï´Ù. ¼ºÀåÀ» À¯ÁöÇÏ·Á¸é ³ôÀº ºñ¿ë°ú ±ÔÁ¦ º¹À⼺°ú °°Àº ¹®Á¦¸¦ ÇØ°áÇØ¾ß ÇÕ´Ï´Ù. ¾÷°è °¢»ç´Â ÁøÈ­ÇÏ´Â ÇコÄÉ¾î ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ AI ÅëÇÕ°ú Çõ½ÅÀûÀÎ Á¦Ç° ÅõÀÔ¿¡ ÁÖ·ÂÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀÌÁ¡

¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?

¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç°¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°ú ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ÇöȲ

Á¦3Àå ºñÁî´Ï½º »óȲ

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå ´Éµ¿ À̽ÄÇü ÀÇ·á±â±â(AIMD) ½ÃÀå : Á¦Ç°º°

Á¦6Àå ´Éµ¿ À̽ÄÇü ÀÇ·á±â±â(AIMD) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦7Àå ´Éµ¿ À̽ÄÇü ÀÇ·á±â±â(AIMD) ½ÃÀå : Áö¿ªº°

Á¦8Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦10Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Active Implantable Medical Devices (AIMD) Market is expected to grow from USD 35.195 billion in 2025 to USD 49.197 billion in 2030, at a CAGR of 6.93%.

The global active implantable medical devices (AIMD) market is experiencing significant growth, driven by technological advancements, an aging population, and the rising prevalence of chronic diseases. AIMDs, such as pacemakers and neurostimulators, are critical for monitoring and treating conditions, particularly in geriatric patients.

Market Drivers

1. Rising Prevalence of Chronic Diseases in the Aging Population: The growing incidence of chronic conditions, such as cardiovascular diseases, diabetes, and neurological disorders, among older adults is a primary driver of the AIMD market. These devices play a vital role in managing complex healthcare needs, improving patient outcomes, and enhancing quality of life. The increasing elderly population globally amplifies demand for AIMDs, as healthcare providers seek advanced solutions to address age-related health challenges.

2. Technological Advancements and AI Integration: Innovations in AIMD technology, including the integration of artificial intelligence (AI) for patient-specific diagnostics, are propelling market growth. AI-enabled devices enhance monitoring precision and treatment efficacy, driving adoption. Ongoing research and development, along with expanded indications for existing AIMDs, further fuel innovation, positioning the market for sustained growth.

3. Supportive Government Policies and Funding: Regulatory frameworks, such as the Republic of Korea's Act on Fostering the Medical Devices Industry and Supporting Innovative Medical Devices, are fostering AIMD development. Government funding and increased awareness of AIMD benefits are encouraging investment in research and product launches, supporting market expansion.

Market Restraints

1. High Costs and Regulatory Challenges: The high cost of developing and manufacturing AIMDs, coupled with stringent regulatory requirements, poses challenges to market growth. Compliance with diverse global standards increases production costs and timelines, potentially limiting accessibility in cost-sensitive markets.

2. Limited Awareness in Emerging Markets: Despite growing demand, limited awareness of AIMD benefits in certain regions, particularly in developing economies, may hinder market penetration. Educating healthcare providers and patients about the advantages of AIMDs remains a critical challenge.

Geographical Outlook

Key Developments (2023-2025)

Market Outlook

The AIMD market is poised for robust growth through 2025, driven by the rising burden of chronic diseases, technological advancements, and supportive policies. The U.S. leads due to its aging population and high disease prevalence, while Asia-Pacific shows strong potential. Challenges such as high costs and regulatory complexities must be addressed to sustain growth. Industry players are expected to focus on AI integration and innovative product launches to meet evolving healthcare demands.

Key Benefits of this Report:

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Active Implantable Medical Devices (AIMD) Market Segmentation:

By Product

By End-User

By Geography

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

3. BUSINESS LANDSCAPE

4. TECHNOLOGICAL OUTLOOK

5. ACTIVE IMPLANTABLE MEDICAL DEVICES (AIMD) MARKET BY PRODUCT

6. ACTIVE IMPLANTABLE MEDICAL DEVICES (AIMD) MARKET BY END-USER

7. ACTIVE IMPLANTABLE MEDICAL DEVICES (AIMD) MARKET BY GEOGRAPHY

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

9. COMPANY PROFILES

10. APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â